These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32044284)

  • 41. Omega-3 phospholipids and obesity-associated NAFLD: Potential mechanisms and therapeutic perspectives.
    Mitrovic M; Sistilli G; Horakova O; Rossmeisl M
    Eur J Clin Invest; 2022 Mar; 52(3):e13650. PubMed ID: 34291454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver.
    AlAsfoor S; Rohm TV; Bosch AJT; Dervos T; Calabrese D; Matter MS; Weber A; Cavelti-Weder C
    Sci Rep; 2018 Oct; 8(1):15331. PubMed ID: 30333571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
    Kim YJ; Choi MS; Woo JT; Jeong MJ; Kim SR; Jung UJ
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28116779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucocorticoids and non-alcoholic fatty liver disease.
    Woods CP; Hazlehurst JM; Tomlinson JW
    J Steroid Biochem Mol Biol; 2015 Nov; 154():94-103. PubMed ID: 26241028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
    Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
    Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease.
    Zubáňová V; Červinková Z; Kučera O; Palička V
    Acta Medica (Hradec Kralove); 2021; 64(1):1-7. PubMed ID: 33855952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity.
    Daemen S; Schilling JD
    Front Immunol; 2019; 10():3133. PubMed ID: 32038642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
    Saponaro C; Gaggini M; Gastaldelli A
    Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease.
    Cimini FA; Barchetta I; Ciccarelli G; Leonetti F; Silecchia G; Chiappetta C; Di Cristofano C; Capoccia D; Bertoccini L; Ceccarelli V; Carletti R; Fraioli A; Baroni MG; Morini S; Cavallo MG
    Diabetes Metab Res Rev; 2021 Jan; 37(1):e3358. PubMed ID: 32469428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women.
    Corbould A; Bhathal PS; Dixon JB; O'Brien PE
    Metab Syndr Relat Disord; 2014 Aug; 12(6):311-9. PubMed ID: 24819229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
    Mulder P; Morrison MC; Verschuren L; Liang W; van Bockel JH; Kooistra T; Wielinga PY; Kleemann R
    Sci Rep; 2016 Aug; 6():31542. PubMed ID: 27545964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systems-level organization of non-alcoholic fatty liver disease progression network.
    Shubham K; Vinay L; Vinod PK
    Mol Biosyst; 2017 Aug; 13(9):1898-1911. PubMed ID: 28745372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection.
    Papagianni M; Tziomalos K
    AIDS Rev; 2018; 20(3):171-173. PubMed ID: 30264828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet.
    Baiges-Gaya G; Fernández-Arroyo S; Luciano-Mateo F; Cabré N; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; Romeu M; Nogués MR; Camps J; Joven J
    J Nutr Biochem; 2021 Mar; 89():108559. PubMed ID: 33264665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.